Robotics technology provider CloudMinds has recruited Vision Fund, managed by existing investor SoftBank, for a $300m round that will fund the ramping up of its production capabilities.

Careem has agreed to an acquisition by Uber in a cash-and-convertible note deal, allowing Rakuten, Al Tayyar, Daimler, STC and Didi Chuxing to exit.

The online travel booking platform has collected $44.3m in a round featuring Dunamu as well as a reported $30.7m investment from Kakao.

The CNPG-backed oncology therapy developer boosted its overall funding to $70m in a round backed by Eli Lilly and CICC Capital.

Three weeks after reports suggested SoftBank Vision Fund had led a $395m series F round for e-commerce delivery service Delhivery, the size has been confirmed as $413m.

The immunotherapy developer, which is majority owned by BGI Group, has secured $17.8m in a GF Securities-led round that will fund clinical work on its lead product candidate.

BioLeaders is investing $10m in an as yet unnamed spinout from Weizmann Institute of Science working on a genetic drug for cancer.

The funding will be funnelled into an unnamed p53 suppressor-focused oncology Weizmann spinout and ultrasound guidance device maker On-Sight Medical.

Alibaba, Chongqing Changan Automobile, Dongfeng Motor, FAW, Suning and Tencent have joined forces to form a $1.46bn vehicle that will invest in the on-demand ride space.

The investment firm, which counts several corporates as backers, has completed the first close for a fund with a $1.48bn target, following commitments from China Everbright Trust and two state-backed funds.